Group 1 - Embecta Corp. reported its first quarter fiscal 2026 financial results, continuing its evolution from a company focused on insulin delivery to a broader medical supplies company [1] - The company has a 100-year legacy in insulin delivery and aims to improve lives through innovative solutions and partnerships [3] Group 2 - A conference call and live audio webcast for analysts and investors was scheduled for February 5, 2026, at 8:00 a.m. ET, with a replay available later in the day [2]